Cytokinetics Announces 2024 Annual Meeting of Stockholders on May 15

TL;DR

<b>Cytokinetics will hold its Annual Meeting of Stockholders on May 15, 2024, to elect directors, approve stock plan amendments, ratify auditor, and vote on executive compensation.</b>

AI Summary

CYTOKINETICS INC (CYTK) filed a Proxy Statement (DEF 14A) with the SEC on April 8, 2024. Annual Meeting of Stockholders scheduled for May 15, 2024, at 10:00 a.m. local time. Nominees Robert I. Blum and Robert A. Harrington to be elected as Class II Directors for three-year terms. Proposal to amend and restate the 2015 Employee Stock Purchase Plan to increase authorized shares by 300,000. Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2024. Advisory vote on the compensation of named executive officers.

Why It Matters

For investors and stakeholders tracking CYTOKINETICS INC, this filing contains several important signals. The election of directors and approval of the stock purchase plan amendment are critical for the company's governance and future equity compensation. The advisory vote on executive compensation allows shareholders to voice their opinion on the company's pay practices.

Risk Assessment

Risk Level: low — CYTOKINETICS INC shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new material financial or operational information that would indicate significant risk.

Analyst Insight

Review the proposals for director elections, stock plan amendments, and executive compensation to inform voting decisions.

Key Numbers

• May 15, 2024 — Annual Meeting Date (Date of the Annual Meeting of Stockholders)
• 300,000 — Additional Shares (Increase in authorized shares under the Employee Stock Purchase Plan)
• March 26, 2024 — Record Date (Record date for stockholders entitled to notice and voting)

Key Players & Entities

• Cytokinetics, Incorporated (company) — Registrant
• Robert I. Blum (person) — Nominee for Class II Director
• Robert A. Harrington (person) — Nominee for Class II Director
• Ernst & Young LLP (company) — Independent registered public accounting firm
• John O. Faurescu (person) — Associate General Counsel & Corporate Secretary

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC regulations regarding proxy solicitations and annual meetings.
• Employee Stock Purchase Plan Amendment [low — operational]: Approval of the amendment to increase shares under the ESPP is necessary for continued equity awards.

Key Dates

• 2024-05-15: Annual Meeting of Stockholders — Key date for voting on corporate matters and electing directors.
• 2024-03-26: Record Date — Determines which stockholders are eligible to vote at the annual meeting.

Glossary

DEF 14A

Definitive Proxy Statement filed with the SEC. (Provides detailed information to shareholders about matters to be voted on at the annual meeting.)

Class II Directors

Directors elected for a specific term, typically part of a classified board structure. (Relevant to the election of board members and company governance.)

Employee Stock Purchase Plan (ESPP)

A plan allowing employees to purchase company stock, often at a discount. (The amendment to increase authorized shares impacts the company's ability to grant equity compensation.)

Key Financial Figures

• $0.001 — utstanding, designated as common stock, $0.001 par value per share (the "Common Stock"

Filing Documents

• ny20020788x1_def14a.htm (DEF 14A) — 1592KB
• ny20020788x1_board.jpg (GRAPHIC) — 245KB
• ny20020788x1_location.jpg (GRAPHIC) — 10KB
• ny20020788x1_record.jpg (GRAPHIC) — 10KB
• ny20020788x1_time.jpg (GRAPHIC) — 10KB
• logo_cytokinetics2.jpg (GRAPHIC) — 14KB
• ny20020788x1_pc01.jpg (GRAPHIC) — 621KB
• ny20020788x1_pc02.jpg (GRAPHIC) — 502KB
• 0001140361-24-018628.txt (&nbsp;) — 6195KB
• cytk-20240515.xsd (EX-101.SCH) — 5KB
• cytk-20240515_def.xml (EX-101.DEF) — 5KB
• cytk-20240515_lab.xml (EX-101.LAB) — 10KB
• cytk-20240515_pre.xml (EX-101.PRE) — 5KB
• ny20020788x1_def14a_htm.xml (XML) — 311KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 14 Board of Directors 17 Director Skills, Experience and Background 18 Summary of Director Core Experiences and Skills 22 Board of Directors Leadership Structure 23 Board of Directors Role in Risk Oversight 23 Independence of Directors 24 Directors Commitments; Board Responsiveness 24 Board of Directors Meetings and Committees 25 TABLE OF CONTENTS Corporate Responsibility 27 Communicating with the Board of Directors 27 Executive Officers 28 Executive Officer Skills, Experience and Background 28

Executive Compensation

Executive Compensation 29 Compensation Discussion and Analysis 29 Compensation and Talent Committee Report 40 Compensation Committee Interlocks and Insider Participation 41 Risk Analysis of the Compensation Programs 41 Executive Summary Compensation Table for 2023 42 Grants of Plan-Based Awards in 2023 43 Outstanding Equity Awards at December 31, 2023 44 Option Exercises and Stock Vested in 2023 46 Executive Employment and Other Agreements 46 Pension Benefits 46 Nonqualified Deferred Compensation 46 Potential Payments Upon Termination or Change of Control 46 Principal Executive Officer Pay Ratio 48 Pay Versus Performance 49 Equity Compensation Plans at December 31, 2023 52 Director Compensation 53 Annual Retainers 53 Election to Receive Retainers in Cash or Equity 54 Initial and Annual Equity Grants to Non-Employee Directors 54 Director Compensation Table for 2023 55 Delinquent Section 16(a) Reports 56 Certain Business Relationships and Related Party Transactions 56 Review, Approval or Ratification of Transactions with Related Parties 56 Indemnification of Directors and Officers 56 Householding of Proxy Materials 57 Other Matters 57 Appendix Appendix A Amended and Restated 2015 Employee Stock Purchase Plan A-1 TABLE OF CONTENTS 350 Oyster Point Blvd. South San Francisco, California 94080 Proxy Statement for the 2024 Annual Meeting of Stockholders May 15, 2024 Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting to Be Held on Wednesday, May 15, 2024 at 10:00 a.m. local time at 350 Oyster Point Blvd., South San Francisco, CA 94080 The Notice of Annual Meeting, Proxy Statement and annual report to stockholders are available at proxydocs.com/CYTK. We intend to mail these proxy materials on or about April 8, 2024 to all stockholders of record entitled to vote at the 2024 annual meeting. MEETING DETAILS Time and Date May 15, 2024 at 1

View Full Filing

View this DEF 14A filing on SEC EDGAR